Overview

A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to examine the safety, tolerability, and effects on hearing thresholds of two single doses of PF-04958242 and placebo in subjects with age-related hearing loss.
Phase:
Phase 1
Details
Lead Sponsor:
Biogen
Pfizer